Lazard Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.73M	Buy	131,351 +57,633	+78%	+$757K	﹤0.01%	1061
2025 Q1	$1.06M	Buy	73,718 +529	+0.7%	+$7.61K	﹤0.01%	1196
2024 Q4	$1.23M	Buy	+73,189	New	+$1.23M	﹤0.01%	1066